Research

Hormonal

Long-chain n-3 polyunsaturated fatty acids (omega-3) improve insulin sensitivity and glucose homeostasis in animal models of metabolic syndrome, but have none or marginal effects on metabolic control in human Type 2 diabetes patients.

If you have Type 2 Diabetes, taking omega-3 supplements (EPA/DHA) will likely not improve your blood sugar control or insulin sensitivity, even though it may help lower your triglycerides. Do not rely on omega-3s to manage your glucose levels; continue with prescribed antidiabetic medications and lifestyle changes.

GoodQualifiesHIGH confidence
Most animal experiments document beneficial effects of omega-3 on insulin sensitivity and glucose metabolism even under conditions of established obesity and insulin resistance... The results of a majority of clinical trials performed in T2D patients suggest that omega-3 have none or marginal effects on metabolic control, while effectively reducing hypertriglyceridemia in these patients.
Pavel Flachs et al. · Physiological Research · 2014

Why this rating

Based on a comprehensive review of multiple animal studies and clinical trials.

Source

The Effect of n-3 Fatty Acids on Glucose Homeostasis and Insulin Sensitivity

Pavel Flachs et al. · Physiological Research · 2014

DOI 10.33549/physiolres.932715

narrative_reviewCited 183×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →